American Oriental Bioengineering Inc. (NYSE:AOB) announced financial results for the second quarter ended June 30, 2011. In the second quarter of 2011, revenue decreased to $54.1 million from $77.3 million in the same period of 2010. The Company generated revenue of $50.3 million from its manufacturing business in the second quarter of 2011 compared with $73.7 million in the prior year period. Revenue from pharmaceutical products decreased to $40.7 million from $63.8 million in the prior year period. Nutraceutical products generated revenue of approximately $9.5 million in the second quarter of 2011, compared to $9.9 million in the prior year period. decreased the manufacturing of certain generic drugs strategically shifted the products mix toward higher-margin products from lower margin products in order to minimize the impact from the increased cost of certain raw materials and the continuing government price cut on certain products.

To read more: http://drstockpick.com/?p=21683